Zhongnan Medical Journal Press

Home Results

A total of 177 result was found. Results that relate to Drug

Signal mining and analysis of adverse events of four LAMA drugs based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1081-1090.
396 times 90 times

QIN Honghua GUO Haiyan YANG Liu WANG Ying TONG Xiaona LI Haifeng

Aclidinium bromide Glycopyrronium bromide Umeclidinium bromide Tiotropium bromide Adverse drug event Signal mining Pharmacovigilance FAERS database
Details
Signal mining for cutaneous adverse events associated with antibody-drug conjugates based on FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1091-1098.
331 times 76 times

QIAN Mengying ZHANG Yongyi SHAN Qing CHEN Yan LI Bing GUO Jinmin

Antibody-drug conjugate Cutaneous adverse event FAERS database Data mining Pharmacovigilance
Details
A case of acute kidney injury caused by oral sodium phosphate

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1183-1188.
309 times 61 times

PENG Qin WU Wenfeng WU Huiyi

Sodium phosphate oral solution Acute kidney injury Hypertension Adverse drug reaction
Details
A case report of psoriasis-like rash caused by tislelizumab

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1189-1195.
322 times 60 times

LI Jie WANG Ronghua XIE Xiaolei

Tislelizumab Psoriasis-like rash Adverse drug reaction
Details
One case of anaphylaxis caused by pembrolizumab injection

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1196-1200.
287 times 62 times

HUANG Shuzhen CHEN Xiongjian

Pembrolizumab Anaphylaxis Adverse drug reaction
Details
Implementation and interpretation for proficiency testing of microbiological examination

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):229-236.
395 times 37 times

LI Zhiyuan ZHANG Jingyi WANG Siqi LI Zheyuan LIU Yi ZOU Weibin

Proficiency testing Non-sterile drugs Microbiological examination Implementation and interpretation
Details
Research progress of novel anti-VEGF therapy in the treatment of neovascular age-related macular degeneration with novel drugs

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):268-277.
438 times 42 times

HOU Huimin CHANG Xueke ZHANG Leying SONG Zongming

Neovascular age-related macular degeneration Pathogenesis Novel drugs
Details
Clinical application and research progress on drugs for treating dry eyes

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):278-289.
437 times 49 times

SHANG Peizhao JIANG Siqi JIN Min CUI Yulong ZHOU Quanying LI Lingjun

Dry eye Medication Permeation pathways Artificial tears Secretagogue Inflammatory pathways Nonsteroidal antiinflammatory drugs Corticosteroids Clinical application Research progress
Details
Research progress on the mechanism of genistein in Alzheimer's disease

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):290-299.
353 times 38 times

ZHAO Mingyong LING Yingchun LI Lingling ZHONG Fangfang

Genistein Phytoactive drugs Alzheimer's disease Neuroprotective Estrogen Research progress
Details
Research progress on drug resistance mechanism and treatment of drug-resistant tuberculosis

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):341-349.
495 times 41 times

ZHONG Shanshan PENG Yu MAO Rongrong WANG Fang FAN Sitong CHEN Jiajia

Drug-resistant tuberculosis Mechanisms of drug resistance Treatment Research progress Mycobacterium tuberculosis
Details
Current status and quality evaluation of domestic and foreign ophthalmic drug and device combination products

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):350-356.
399 times 36 times

WEI Zhihan HUANG Yuanli ZHAO Danmei DU Xiaodan KE Linnan XU Yun

Ophthalmology Drug-device combination products Corneal contact lenses Punctual plugs Intraocular lens Quality evaluation
Details
A case of toxic epidermal necrolysis caused by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology New Online
224 times 37 times

HUANG Lingling LI Xialin HUANG Guangyao LUO Peng WANG Weimin WANG Junping

Pembrolizumab Lung cancer Toxic epidermal necrolysis Adverse drug reaction
Details